Bridging the gap between complex medical jargon and patient understanding through AI-driven visualization. B2B, B2C
MedGlance AI has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2026.
MedGlance AI's investors include Springboard Health Angels, Stanford Angels & Entrepreneurs United.
MedGlance AI is headquartered in San Francisco, United States.
Bridging the gap between complex medical jargon and patient understanding through AI-driven visualization. B2B, B2C
MedGlance AI is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MedGlance AI — Funding & Investors." VCBacked, February 12, 2026, https://www.vcbacked.co/company/medglance-ai. Accessed August 14, 2026.
VCBacked. (2026). MedGlance AI — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/medglance-ai
{{cite web |title=MedGlance AI — Funding & Investors |url=https://www.vcbacked.co/company/medglance-ai |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated